Suppr超能文献

L13a从60S核糖体亚基的调控释放作为转录本特异性翻译控制的一种机制。

Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control.

作者信息

Mazumder Barsanjit, Sampath Prabha, Seshadri Vasudevan, Maitra Ratan K, DiCorleto Paul E, Fox Paul L

机构信息

Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA.

出版信息

Cell. 2003 Oct 17;115(2):187-98. doi: 10.1016/s0092-8674(03)00773-6.

Abstract

Transcript-specific translational control is generally directed by binding of trans-acting proteins to structural elements in the untranslated region (UTR) of the target mRNA. Here, we elucidate a translational silencing mechanism involving regulated release of an integral ribosomal protein and subsequent binding to its target mRNA. Human ribosomal protein L13a was identified as a candidate interferon-Gamma-Activated Inhibitor of Translation (GAIT) of ceruloplasmin (Cp) mRNA by a genetic screen for Cp 3'-UTR binding proteins. In vitro activity of L13a was shown by inhibition of target mRNA translation by recombinant protein. In response to interferon-gamma in vivo, the entire cellular pool of L13a was phosphorylated and released from the 60S ribosomal subunit. Released L13a specifically bound the 3'-UTR GAIT element of Cp mRNA and silenced translation. We propose a model in which the ribosome functions not only as a protein synthesis machine, but also as a depot for regulatory proteins that modulate translation.

摘要

转录本特异性的翻译控制通常是由反式作用蛋白与靶标mRNA非翻译区(UTR)中的结构元件结合来指导的。在此,我们阐明了一种翻译沉默机制,该机制涉及一种核糖体整合蛋白的调控性释放以及随后与靶标mRNA的结合。通过对铜蓝蛋白(Cp)mRNA的3'-UTR结合蛋白进行遗传筛选,人类核糖体蛋白L13a被鉴定为铜蓝蛋白(Cp)mRNA的一种候选干扰素-γ激活的翻译抑制剂(GAIT)。重组蛋白对靶标mRNA翻译的抑制作用证明了L13a的体外活性。在体内对干扰素-γ作出反应时,L13a的整个细胞池被磷酸化并从60S核糖体亚基释放出来。释放出来的L13a特异性地结合Cp mRNA的3'-UTR GAIT元件并使翻译沉默。我们提出了一个模型,其中核糖体不仅作为蛋白质合成机器发挥作用,而且还作为调节翻译的调控蛋白的储存库。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验